SPC Editorial Director David Bronstein talks with Aimee Tharaldson, PharmD, senior clinical consultant, Emerging Therapeutics at Express Scripts, about how the recently approved specialty drugs will affect pharmacists and why cheaper biosimilars are not making it onto formularies.